Return to Common Drugs Index
terconazole
Terazol 3, Terazol 7

Pregnancy Risk Category C

How supplied
Vaginal cream:
0.4%, 0.8%
Vaginal suppositories:
80 mg

Action
Unknown. May increase fungal cell membrane permeability (Candida species only).

Indications & dosage
Vulvovaginal candidiasis--

Adults:
1 applicator of cream or 1 suppository inserted into vagina h.s.; 0.4% cream used for 7 consecutive days; 0.8% cream or 80-mg suppository for 3 consecutive days. Course repeated, if needed, after reconfirmation by smear or culture.

Adverse reactions
CNS:
headache.
GI:
abdominal pain.
GU:
dysmenorrhea, pain of female genitalia, vulvovaginal burning.
Skin:
irritation, pruritus, photosensitivity.
Other:
fever, chills, body aches.

Interactions
None significant.

Effects on diagnostic tests
None reported.

Contraindications
Contraindicated in patients with sensitivity to drug or its inactive ingredients.

Nursing considerations

Patient teaching

*Liquid contains alcohol. **May contain tartrazine.  †Canada  ‡Australia  §U.K.  OTCOver the counter
Reactions may be common, uncommon, life-threatening, or COMMON AND LIFE-THREATENING

Return to Common Drugs Index